Case number 2017-2487
Nuvo Pharmaceuticals v. Dr. Reddy's Laboratories Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | NUVO PHARMACEUTICALS v. DR. REDDY'S LABORATORIES INC. [OPINION - NONPRECEDENTIAL] [nonprecedential] (0) |
| Sep 13, 2019 | 14 | Mandate issued to the United States District Court for the District of New Jersey. Service as of this date by the Clerk of Court. [635286] [17-2487, 17-2488] [JAB] [Entered: 09/13/2019 11:22 AM] (2) |
| Aug 7, 2019 | 12 | OPINION filed for the court by Prost, Chief Judge; Clevenger, Circuit Judge and Wallach, Circuit Judge. Nonprecedential Per Curiam Opinion. [626582] [17-2487, 17-2488] [MJL] [Entered: 08/07/2019 09:42 AM] (3) |
| Aug 7, 2019 | 13 | JUDGMENT. REVERSED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [626584] [17-2487, 17-2488] [MJL] [Entered: 08/07/2019 09:43 AM] (2) |
| Aug 5, 2019 | 11 | ORDER filed lifting stay. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [625964] [JAB] [Entered: 08/05/2019 12:12 PM] (2) |
| Aug 2, 2019 | 9 | RESPONSE of Appellees Horizon Medicines LLC and Nuvo Pharmaceuticals (Ireland) Designated Activity Company to the court order to show cause [8] , court order [8]. Service: 08/02/2019 by email. [625819] [17-2487] [Charles Collins-Chase] [Entered: 08/02/2019 06:02 PM] (9) |
| Aug 2, 2019 | 10 | RESPONSE of Appellants Lupin Ltd. and Lupin Pharmaceuticals, Inc. to the court order to show cause [8] , court order [8]. Service: 08/02/2019 by email. [625848] [17-2487] [Sailesh Patel] [Entered: 08/02/2019 10:59 PM] (5) |
| Jul 31, 2019 | 8 | ORDER filed. The parties are hereby ordered to show cause, before the close of business August 2, 2019, why the stay in these two appeals should not be lifted. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [624744] [JAB] [Entered: 07/31/2019 09:38 AM] (2) |
| Jun 7, 2019 | 7 | Status report for Appellees Horizon Medicines LLC, Nuvo Pharmaceuticals (Ireland) Designated Activity Company and Appellants Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 06/07/2019 by email. [612592] [17-2487] [Charles Collins-Chase] [Entered: 06/07/2019 07:14 PM] (11) |
| May 8, 2019 | 4 | ORDER filed. The motion [604519-2] is granted to the extent that: (1) 17-2487 and 17-2488 are deconsolidated from 17-2473, consolidated together, and stayed; (2) The parties to 17-2487, -2488 shall file a joint status report within 30 days; (3) The revised official captions are reflected in the order. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [605764] [17-2473, 17-2487, 17-2488] [JAB] [Entered: 05/08/2019 10:01 AM] (3) |
| May 8, 2019 | 5 | Note to file: The following cases are consolidated: 17-2487 (Lead) with 17-2488 (Member). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [605769] [17-2487, 17-2488] [JAB] [Entered: 05/08/2019 10:19 AM] (0) |
| May 8, 2019 | 6 | NOTE TO FILE: FOR PRIOR ENTRIES SEE 17-2473. [605770] [JAB] [Entered: 05/08/2019 10:20 AM] (0) |
| Feb 25, 2019 | 3 | ORDER filed granting motion to reschedule argument [588056-2] filed by Cross-Appellants Horizon Pharma, Inc. and Nuvo Pharmaceuticals (Ireland) Designated Activity Company in 17-2473. By: Per Curiam. Service as of this date by the Clerk of Court. [588252] [17-2473, 17-2481, 17-2484, 17-2486, 17-2487, 17-2488, 17-2489, 17-2491, 17-2492, 17-2493] [PBC] [Entered: 02/25/2019 09:19 AM] (2) |
| Aug 25, 2017 | 1 | Appeal docketed. Received: 08/21/2017. [456679] [JB] [Entered: 08/25/2017 12:33 PM] (81) |
| Aug 25, 2017 | 2 | Note to file: The following cases are consolidated: 17-2473 Lead with 17-2481,17-2484, 17-2486, 17-2487, 17-2488 (MEMBER CASES) and 17-2489, 17-2491, 17-2492, 17-2493 (CROSS-APPEALS). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [456764] [JB] [Entered: 08/25/2017 03:08 PM] (0) |
